Literature DB >> 3358285

Assessment of two tests for the diagnosis of canine hyperadrenocorticism.

A Rijnberk1, A van Wees, J A Mol.   

Abstract

The low-dose dexamethasone suppression test and the urinary corticoid/creatinine ratio were assessed in 166 and 150 dogs, respectively, for their value in the diagnosis of hyperadrenocorticism. The diagnostic accuracy of the low-dose dexamethasone suppression test was 0.83, with a 95 per cent confidence interval from 0.76 to 0.88. The urinary corticoid/creatinine ratio had a diagnostic accuracy of 0.91 with a 95 per cent confidence interval from 0.85 to 0.95. The high predictive value of a negative corticoid/creatinine ratio (0.98; confidence interval 0.80 to 1.00) and the low cost of this test makes it preferable for screening purposes to the low-dose dexamethasone suppression test for which the predictive value of a negative test was calculated as 0.5g (confidence interval 0.43 to 0.73).

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3358285     DOI: 10.1136/vr.122.8.178

Source DB:  PubMed          Journal:  Vet Rec        ISSN: 0042-4900            Impact factor:   2.695


  15 in total

1.  Effects of a branched-chain amino acid-enriched diet on chronic hepatic encephalopathy in dogs.

Authors:  H P Meyer; R A Chamuleau; D A Legemate; J A Mol; J Rothuizen
Journal:  Metab Brain Dis       Date:  1999-06       Impact factor: 3.584

2.  Expression and functional analysis of dopamine receptor subtype 2 and somatostatin receptor subtypes in canine cushing's disease.

Authors:  C de Bruin; J M Hanson; B P Meij; H S Kooistra; A M Waaijers; P Uitterlinden; S W J Lamberts; L J Hofland
Journal:  Endocrinology       Date:  2008-05-15       Impact factor: 4.736

3.  Cortisol urinary metabolites in dogs with hypercortisolism, congestive heart failure, and healthy dogs: pilot investigation.

Authors:  Ester Quilez; Richard K Burchell; Eric B Thorstensen; Karin Weidgraaf; Stacey E Parbhu; Nicolas Lopez-Villalobos; Arnon Gal
Journal:  J Vet Diagn Invest       Date:  2020-01-10       Impact factor: 1.279

4.  Patterns of the low-dose dexamethasone suppression test in canine hyperadrenocorticism revisited.

Authors:  Florian K Zeugswetter; Alejandra Carranza Valencia; Kerstin Glavassevich; Ilse Schwendenwein
Journal:  Vet Clin Pathol       Date:  2021-03-16       Impact factor: 1.180

5.  Validation study of canine serum cortisol measurement with the Immulite 2000 Xpi cortisol immunoassay.

Authors:  Jérémie Korchia; Kathleen P Freeman
Journal:  J Vet Diagn Invest       Date:  2021-07-22       Impact factor: 1.569

6.  Frequency and risk factors for naturally occurring Cushing's syndrome in dogs attending UK primary-care practices.

Authors:  I Schofield; D C Brodbelt; S J M Niessen; D B Church; R F Geddes; D G O'Neill
Journal:  J Small Anim Pract       Date:  2021-12-08       Impact factor: 1.669

7.  Urinary corticoid concentrations measured by 5 different immunoassays and gas chromatography-mass spectrometry in healthy dogs and dogs with hypercortisolism at home and in the hospital.

Authors:  L Galeandro; N S Sieber-Ruckstuhl; B Riond; S Hartnack; R Hofmann-Lehmann; C E Reusch; F S Boretti
Journal:  J Vet Intern Med       Date:  2014-07-16       Impact factor: 3.333

8.  Clinical Relationship between Cholestatic Disease and Pituitary-Dependent Hyperadrenocorticism in Dogs: A Retrospective Case Series.

Authors:  K-H Kim; S-M Han; K-O Jeon; H-T Kim; Q Li; M-O Ryu; W-J Song; S-C Park; H-Y Youn
Journal:  J Vet Intern Med       Date:  2017-01-08       Impact factor: 3.333

Review 9.  Volumetric Modulated Arc (Radio) Therapy in Pets Treatment: The "La Cittadina Fondazione" Experience.

Authors:  Mario Dolera; Luca Malfassi; Nancy Carrara; Sara Finesso; Silvia Marcarini; Giovanni Mazza; Simone Pavesi; Massimo Sala; Gaetano Urso
Journal:  Cancers (Basel)       Date:  2018-01-24       Impact factor: 6.639

10.  Validation study of canine urine cortisol measurement with the Immulite 2000 Xpi cortisol immunoassay.

Authors:  Jeremie Korchia; Kathleen P Freeman
Journal:  J Vet Diagn Invest       Date:  2021-07-18       Impact factor: 1.569

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.